Research ArticleArticle
Dose-dependent Pharmacological Response to Rituximab in the Treatment of Antineutrophil Cytoplasmic Antibody-associated Vasculitis
Jason M. Springer and Ryan S. Funk
The Journal of Rheumatology August 2021, jrheum.210361; DOI: https://doi.org/10.3899/jrheum.210361
Jason M. Springer
Support for this work was provided by a Clinical and Translational Science Awards grant from the National Center for Advancing Translational Sciences awarded to the University of Kansas for Frontiers: University of Kansas Clinical and Translational Science Institute (# UL1TR002366 and #KL2TR00236), and by a COBRE grant from the National Institute for General Medical Sciences awarded to the Kansas Institute for Precision Medicine (# P20GM130423). J.M. Springer, Associate Professor, MD, MS, Division of Rheumatology and Immunology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee; R.S. Funk, Associate Professor, PharmD, PhD, Department of Pharmacy Practice, University of Kansas Medical Center, Kansas City, Kansas, USA. The authors report no financial conflicts of interest relevant to this article. Address correspondence to Dr. R.S. Funk, University of Kansas Medical Center, Department of Pharmacy Practice, 3901 Rainbow Blvd, KLSIC 4073, Kansas City, KS 66160, USA. Email: ryanfunk@kumc.edu. Accepted for publication July 14, 2021.
Ryan S. Funk
Support for this work was provided by a Clinical and Translational Science Awards grant from the National Center for Advancing Translational Sciences awarded to the University of Kansas for Frontiers: University of Kansas Clinical and Translational Science Institute (# UL1TR002366 and #KL2TR00236), and by a COBRE grant from the National Institute for General Medical Sciences awarded to the Kansas Institute for Precision Medicine (# P20GM130423). J.M. Springer, Associate Professor, MD, MS, Division of Rheumatology and Immunology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee; R.S. Funk, Associate Professor, PharmD, PhD, Department of Pharmacy Practice, University of Kansas Medical Center, Kansas City, Kansas, USA. The authors report no financial conflicts of interest relevant to this article. Address correspondence to Dr. R.S. Funk, University of Kansas Medical Center, Department of Pharmacy Practice, 3901 Rainbow Blvd, KLSIC 4073, Kansas City, KS 66160, USA. Email: ryanfunk@kumc.edu. Accepted for publication July 14, 2021.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Dose-dependent Pharmacological Response to Rituximab in the Treatment of Antineutrophil Cytoplasmic Antibody-associated Vasculitis
Jason M. Springer, Ryan S. Funk
The Journal of Rheumatology Aug 2021, jrheum.210361; DOI: 10.3899/jrheum.210361